by Brooke Blazr | Feb 26, 2026 | High Dispatch
Yale University is one of the pioneering institutions in psilocybin research. So much so that they have their own multidisciplinary program dedicated to studying the effects of psychedelic agents and their therapeutic potential. They are currently running several...
by Brooke Blazr | Feb 25, 2026 | High Dispatch
Here’s something that should fundamentally change how we think about autism and cannabis: autistic children have significantly reduced plasma levels of endocannabinoids. The endocannabinoid system (ECS) is a ubiquitous neuromodulatory network that regulates...
by Brooke Blazr | Feb 24, 2026 | High Dispatch
The pharmacological difference between natural THC and synthetic cannabinoids like K2 is the difference between a partial agonist and a full agonist. THC, the active compound in cannabis, partially activates the CB1 receptor in your brain. There is a biological...
by Brooke Blazr | Feb 23, 2026 | High Dispatch
Every year, as the light softens over the hills of Humboldt and Mendocino, the cannabis world turns its attention to one of the most influential genetic selection events in the United States: the Humboldt Seed Company (HSC) Pheno Hunt. What began as a small internal...
by Brooke Blazr | Feb 23, 2026 | High Dispatch
Here’s the reality that gets buried under every sensationalized headline about “marijuana-induced madness”: the baseline annual incidence of psychotic disorders in the general population is approximately 0.0027%. That’s 2.7 cases per 100,000...
by Brooke Blazr | Feb 21, 2026 | High Dispatch
For generations, the Vlasic name has stood for consistency and quality. First through a Detroit dairy, then as America’s most famous pickle jar with its iconic smiling stork. Entrepreneur Willy Vlasic is carrying that entrepreneurial legacy forward in his own way for...
